Lead Toxicity Differential Diagnoses
- Author: Pranay Kathuria, MD; Chief Editor: Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS more...
Confusional States and Acute Memory Disorders
Constipation in Emergency Medicine
Emergent Management of Guillain-Barre Syndrome
Fadrowski JJ, Navas-Acien A, Tellez-Plaza M, Guallar E, Weaver VM, Furth SL. Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Arch Intern Med. 2010 Jan 11. 170(1):75-82. [Medline].
Murata K, Iwata T, Dakeishi M, Karita K. Lead toxicity: does the critical level of lead resulting in adverse effects differ between adults and children?. J Occup Health. 2009. 51(1):1-12. [Medline].
Berg R. Lead in adults: the lesser concern rears its head. J Environ Health. 2009 Dec. 72(5):8-13. [Medline].
Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med. 2003 Apr 17. 348(16):1517-26. [Medline].
Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics. 1992 Dec. 90(6):855-61. [Medline].
Chen A, Dietrich KN, Ware JH, Radcliffe J, Rogan WJ. IQ and blood lead from 2 to 7 years of age: are the effects in older children the residual of high blood lead concentrations in 2-year-olds?. Environ Health Perspect. 2005 May. 113(5):597-601. [Medline]. [Full Text].
Hornung R, Lanphear B, Dietrich K. Response to: "What is the meaning of non-linear dose-response relationships between blood lead concentration and IQ?". Neurotoxicology. 2006 Jul. 27(4):635. [Medline].
Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect. 2005 Jul. 113(7):894-9. [Medline]. [Full Text].
Herman SS, Geraldine M, Venkatesh T. Influence of minerals on lead-induced alterations in liver function in rats exposed to long-term lead exposure. J of Hazardous Materials. In press.
Elevated Lead in D.C. Drinking Water - A Study of Potential Causative Events, Final Summary Report. EPA; August 2007:[Full Text].
Onuah, F and Abrak, I. At Least 28 Children Killed by Lead Poisoning in Nigeria. Medscape Medical News. Available at http://www.medscape.com/viewarticle/844746. May 18, 2015; Accessed: September 22, 2015.
Holstege CP, Ferguson JD, Wolf CE, Baer AB, Poklis A. Analysis of moonshine for contaminants. J Toxicol Clin Toxicol. 2004. 42(5):597-601. [Medline].
Cristante AF, de Souza FI, Barros Filho TE, Oliveira RP, Marcon RM. Lead poisoning by intradiscal firearm bullet: a case report. Spine (Phila Pa 1976). 2010 Feb 15. 35(4):E140-3. [Medline].
Norman EH, Bordley WC, Hertz-Picciotto I, Newton DA. Rural-urban blood lead differences in North Carolina children. Pediatrics. 1994 Jul. 94(1):59-64. [Medline].
Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, et al. Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988-2004. Pediatrics. 2009 Mar. 123(3):e376-85. [Medline].
CDC. US Department of Health and Human Services, National Institute for Occupational Safety and Health; 2013. Adult Blood Lead Epidemiology and Surveillance (ABLES). [Full Text].
Guérin O, Carré N, Garnier R. [Determining factors in lowering blood lead levels below the poisoning threshold in Greater Paris (1992-2006)]. Rev Epidemiol Sante Publique. 2010 Jun. 58(3):181-7. [Medline].
Evans M, Fored CM, Nise G, Bellocco R, Nyrén O, Elinder CG. Occupational lead exposure and severe CKD: a population-based case-control and prospective observational cohort study in Sweden. Am J Kidney Dis. 2010 Mar. 55(3):497-506. [Medline].
Morgan BW, Todd KH, Moore B. Elevated blood lead levels in urban moonshine drinkers. Ann Emerg Med. 2001 Jan. 37(1):51-4. [Medline].
Dietrich KN, Berger OG, Succop PA. Lead exposure and the motor developmental status of urban six-year-old children in the Cincinnati Prospective Study. Pediatrics. 1993 Feb. 91(2):301-7. [Medline].
Fluri F, Balestra G, Christ M, Marsch S, Fuhr P, Rüegg S. Stimulus-induced rhythmic, periodic or ictal discharges (SIRPIDs) elicited by stimulating exclusively the ophthalmic nerve. Clin Neurophysiol. 2008 Aug. 119(8):1934-8. [Medline].
Lead exposure in children: prevention, detection, and management. Pediatrics. 2005 Oct. 116(4):1036-46. [Medline].
American Academy of Pediatrics Committee on Environmental Health. Lead. In:. Handbook of Pediatric Environmental Health. American Academy of Pediatrics. Elk Grove, IL: AAP; 1999:131-43.:
CDC. Preventing Lead Poisoning in Young Children. DC, United States Department of Health and Human Services:1991:[Full Text].
CDC. Screening Young Children for Lead Poisoning. Guidance for State and Local Public Health Officials. . Atlanta, GA: United States Department of Health and Human Services; 1997:[Full Text].
Treatment guidelines for lead exposure in children. American Academy of Pediatrics Committee on Drugs. Pediatrics. 1995 Jul. 96(1 Pt 1):155-60. [Medline].
Carton JA, Maradona JA, Arribas JM. Acute-subacute lead poisoning. Clinical findings and comparative study of diagnostic tests. Arch Intern Med. 1987 Apr. 147(4):697-703. [Medline].
Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, et al. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics. 2004 Jul. 114(1):19-26. [Medline].
Atre AL, Shinde PR, Shinde SN, Wadia RS, Nanivadekar AA, Vaid SJ, et al. Pre- and posttreatment MR imaging findings in lead encephalopathy. AJNR Am J Neuroradiol. 2006 Apr. 27(4):902-3. [Medline].
Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, et al. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med. 2001 May 10. 344(19):1421-6. [Medline].
Thurtle N, Greig J, Cooney L, Amitai Y, Ariti C, Brown MJ, et al. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data. PLoS Med. 2014 Oct. 11 (10):e1001739. [Medline].
Wedeen RP, Malik DK, Batuman V. Detection and treatment of occupational lead nephropathy. Arch Intern Med. 1979 Jan. 139(1):53-7. [Medline].
Lin JL, Ho HH, Yu CC. Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial. Ann Intern Med. 1999 Jan 5. 130(1):7-13. [Medline].
Lin JL, Lin-Tan DT, Hsu KH, Yu CC. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med. 2003 Jan 23. 348(4):277-86. [Medline].
Lin JL, Tan DT, Hsu KH, Yu CC. Environmental lead exposure and progressive renal insufficiency. Arch Intern Med. 2001 Jan 22. 161(2):264-71. [Medline].
Mushak P. Lead remediation and changes in human lead exposure: some physiological and biokinetic dimensions. Sci Total Environ. 2003 Feb 15. 303(1-2):35-50. [Medline].
Roberts JR, Reigart JR, Ebeling M, Hulsey TC. Time required for blood lead levels to decline in nonchelated children. J Toxicol Clin Toxicol. 2001. 39(2):153-60. [Medline].
Rust SW, Kumar P, Burgoon DA, Niemuth NA, Schultz BD. Influence of bone-lead stores on the observed effectiveness of lead hazard intervention. Environ Res. 1999 Oct. 81(3):175-84. [Medline].
Centers for Disease Control and Prevention. Adult blood lead epidemiology and surveillance--United States, 2005-2007. MMWR Morb Mortal Wkly Rep. 2009 Apr 17. 58(14):365-9. [Medline].
Flora G, Gupta D, Tiwari A. Toxicity of lead: A review with recent updates. Interdiscip Toxicol. 2012 Jun. 5 (2):47-58. [Medline].